标题
The chemical evolution of oligonucleotide therapies of clinical utility
作者
关键词
-
出版物
NATURE BIOTECHNOLOGY
Volume 35, Issue 3, Pages 238-248
出版商
Springer Nature
发表日期
2017-02-28
DOI
10.1038/nbt.3765
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Oligonucleotide therapies for disorders of the nervous system
- (2017) Olga Khorkova et al. NATURE BIOTECHNOLOGY
- Oligonucleotide Therapeutics — A New Class of Cholesterol-Lowering Drugs
- (2017) Anastasia Khvorova NEW ENGLAND JOURNAL OF MEDICINE
- A Highly Durable RNAi Therapeutic Inhibitor of PCSK9
- (2017) Kevin Fitzgerald et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synergistic effect of phosphorothioate, 5′-vinylphosphonate and GalNAc modifications for enhancing activity of synthetic siRNA
- (2016) Thazha P. Prakash et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- 5′-(E)-Vinylphosphonate: A Stable Phosphate Mimic Can Improve the RNAi Activity of siRNA-GalNAc Conjugates
- (2016) Rubina Parmar et al. CHEMBIOCHEM
- The Medicinal Chemistry of Therapeutic Oligonucleotides
- (2016) W. Brad Wan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural Basis of Duplex Thermodynamic Stability and Enhanced Nuclease Resistance of 5′-C-Methyl Pyrimidine-Modified Oligonucleotides
- (2016) Alexander V. Kel′in et al. JOURNAL OF ORGANIC CHEMISTRY
- Structural Analysis of Human Argonaute-2 Bound to a Modified siRNA Guide
- (2016) Nicole T. Schirle et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Big win possible for Ionis/Biogen antisense drug in muscular atrophy
- (2016) Ken Garber NATURE BIOTECHNOLOGY
- Translation efficiency of mRNAs is increased by antisense oligonucleotides targeting upstream open reading frames
- (2016) Xue-hai Liang et al. NATURE BIOTECHNOLOGY
- Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy
- (2016) Claudia A. Chiriboga et al. NEUROLOGY
- The delivery of therapeutic oligonucleotides
- (2016) Rudolph L. Juliano NUCLEIC ACIDS RESEARCH
- From the RNA world to the clinic
- (2016) B. A. Sullenger et al. SCIENCE
- Activating frataxin expression by repeat-targeted nucleic acids
- (2016) Liande Li et al. Nature Communications
- Disposition and Pharmacokinetics of a GalNAc3-Conjugated Antisense Oligonucleotide Targeting Human Lipoprotein (a) in Monkeys
- (2016) Rosie Z. Yu et al. Nucleic Acid Therapeutics
- Disposition and Pharmacology of a GalNAc3-conjugated ASO Targeting Human Lipoprotein (a) in Mice
- (2016) Rosie Z Yu et al. Molecular Therapy-Nucleic Acids
- Docosahexaenoic Acid Conjugation Enhances Distribution and Safety of siRNA upon Local Administration in Mouse Brain
- (2016) Mehran Nikan et al. Molecular Therapy-Nucleic Acids
- siRNAmod: A database of experimentally validated chemically modified siRNAs
- (2016) Showkat Ahmad Dar et al. Scientific Reports
- Ribonuclease H1-dependent hepatotoxicity caused by locked nucleic acid-modified gapmer antisense oligonucleotides
- (2016) Takeshi Kasuya et al. Scientific Reports
- siRNA Conjugates Carrying Sequentially Assembled Trivalent N-Acetylgalactosamine Linked Through Nucleosides Elicit Robust Gene Silencing In Vivo in Hepatocytes
- (2015) Shigeo Matsuda et al. ACS Chemical Biology
- Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
- (2015) Richard S. Geary et al. ADVANCED DRUG DELIVERY REVIEWS
- Single-Molecule Imaging Reveals that Argonaute Reshapes the Binding Properties of Its Nucleic Acid Guides
- (2015) William E. Salomon et al. CELL
- Hepatocyte-Specific Delivery of siRNAs Conjugated to Novel Non-nucleosidic TrivalentN-Acetylgalactosamine Elicits Robust Gene Silencing in Vivo
- (2015) Kallanthottathil G. Rajeev et al. CHEMBIOCHEM
- Oligonucleotide therapeutics: chemistry, delivery and clinical progress
- (2015) Vivek K Sharma et al. Future Medicinal Chemistry
- Antisense oligonucleotide–directed inhibition of nonsense-mediated mRNA decay
- (2015) Tomoki T Nomakuchi et al. NATURE BIOTECHNOLOGY
- An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia
- (2015) Alfica Sehgal et al. NATURE MEDICINE
- Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides
- (2015) Kim A. Lennox et al. NUCLEIC ACIDS RESEARCH
- Enhancing antisense efficacy with multimers and multi-targeting oligonucleotides (MTOs) using cleavable linkers
- (2015) Romesh R. Subramanian et al. NUCLEIC ACIDS RESEARCH
- Identification of metabolically stable 5′-phosphate analogs that support single-stranded siRNA activity
- (2015) Thazha P. Prakash et al. NUCLEIC ACIDS RESEARCH
- In silicoandin vitroevaluation of exonic and intronic off-target effects form a critical element of therapeutic ASO gapmer optimization
- (2015) Piotr J. Kamola et al. NUCLEIC ACIDS RESEARCH
- Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts
- (2015) Sebastien A. Burel et al. NUCLEIC ACIDS RESEARCH
- 2′-Fluoro-modified phosphorothioate oligonucleotide can cause rapid degradation of P54nrb and PSF
- (2015) Wen Shen et al. NUCLEIC ACIDS RESEARCH
- Allele-Selective Inhibition of Mutant Huntingtin with 2-Thio- and C5- Triazolylphenyl-Deoxythymidine-Modified Antisense Oligonucleotides
- (2015) Michael E. Østergaard et al. Nucleic Acid Therapeutics
- Hydrophobically Modified siRNAs Silence Huntingtin mRNA in Primary Neurons and Mouse Brain
- (2015) Julia F Alterman et al. Molecular Therapy-Nucleic Acids
- Synthesis of multi-galactose-conjugated 2′-O-methyl oligoribonucleotides and their in vivo imaging with positron emission tomography
- (2014) Jussi Mäkilä et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing
- (2014) Jayaprakash K. Nair et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- In Vivo Evaluation of Candidate Allele-specific Mutant Huntingtin Gene Silencing Antisense Oligonucleotides
- (2014) Amber L Southwell et al. MOLECULAR THERAPY
- Therapeutic targeting of microRNAs: current status and future challenges
- (2014) Zhonghan Li et al. NATURE REVIEWS DRUG DISCOVERY
- Systematic evaluation of antibody-mediated siRNA delivery using an industrial platform of THIOMAB–siRNA conjugates
- (2014) Trinna L. Cuellar et al. NUCLEIC ACIDS RESEARCH
- Targeted delivery of antisense oligonucleotides to hepatocytes using triantennaryN-acetyl galactosamine improves potency 10-fold in mice
- (2014) Thazha P. Prakash et al. NUCLEIC ACIDS RESEARCH
- Structural basis for microRNA targeting
- (2014) N. T. Schirle et al. SCIENCE
- 10th Annual Meeting of the Oligonucleotide Therapeutics Society
- (2014) Keith T. Gagnon et al. Nucleic Acid Therapeutics
- Quantum Mechanical Studies of DNA and LNA
- (2014) Troels Koch et al. Nucleic Acid Therapeutics
- Phosphorothioates, Essential Components of Therapeutic Oligonucleotides
- (2014) Fritz Eckstein Nucleic Acid Therapeutics
- A Kinetic Model Explains Why Shorter and Less Affine Enzyme-recruiting Oligonucleotides Can Be More Potent
- (2014) Lykke Pedersen et al. Molecular Therapy-Nucleic Acids
- Eteplirsen for the treatment of Duchenne muscular dystrophy
- (2013) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- Locked nucleic acid: tighter is different
- (2013) Jonathan K. Watts CHEMICAL COMMUNICATIONS
- The rough endoplasmatic reticulum is a central nucleation site of siRNA-mediated RNA silencing
- (2013) Lukas Stalder et al. EMBO JOURNAL
- Novel Hydrophobically Modified Asymmetric RNAi Compounds (sd-rxRNA) Demonstrate Robust Efficacy in the Eye
- (2013) Michael Byrne et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Delivery materials for siRNA therapeutics
- (2013) Rosemary Kanasty et al. NATURE MATERIALS
- Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis
- (2013) Teresa Coelho et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rational design of antisense oligonucleotides targeting single nucleotide polymorphisms for potent and allele selective suppression of mutant Huntingtin in the CNS
- (2013) Michael E. Østergaard et al. NUCLEIC ACIDS RESEARCH
- Miravirsen (SPC3649) can inhibit the biogenesis of miR-122
- (2013) Luca F. R. Gebert et al. NUCLEIC ACIDS RESEARCH
- 5′ Unlocked Nucleic Acid Modification Improves siRNA Targeting
- (2013) Nicholas M Snead et al. Molecular Therapy-Nucleic Acids
- Single-Stranded RNAs Use RNAi to Potently and Allele-Selectively Inhibit Mutant Huntingtin Expression
- (2012) Dongbo Yu et al. CELL
- Single-Stranded siRNAs Activate RNAi in Animals
- (2012) Walt F. Lima et al. CELL
- RNA-Based Therapeutics: Current Progress and Future Prospects
- (2012) John C. Burnett et al. CHEMISTRY & BIOLOGY
- Designing Chemically Modified Oligonucleotides for Targeted Gene Silencing
- (2012) Glen F. Deleavey et al. CHEMISTRY & BIOLOGY
- Discovering the first microRNA-targeted drug
- (2012) Morten Lindow et al. JOURNAL OF CELL BIOLOGY
- Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation
- (2012) Farzaneh Modarresi et al. NATURE BIOTECHNOLOGY
- siRNA-optimized Modifications for Enhanced In Vivo Activity
- (2012) Denise M Kenski et al. Molecular Therapy-Nucleic Acids
- Unique Gene-Silencing and Structural Properties of 2′-Fluoro-Modified siRNAs
- (2011) Muthiah Manoharan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Stability and Mismatch Discrimination of Locked Nucleic Acid–DNA Duplexes
- (2011) Richard Owczarzy et al. BIOCHEMISTRY
- An Overview of Sugar-Modified Oligonucleotides for Antisense Therapeutics
- (2011) Thazha P. Prakash CHEMISTRY & BIODIVERSITY
- Antisense drug discovery and development
- (2011) Tsuyoshi Yamamoto et al. Future Medicinal Chemistry
- Novel Oligonucleotides Containing Two 3′-Ends Complementary to Target mRNA Show Optimal Gene-Silencing Activity
- (2011) Lakshmi Bhagat et al. JOURNAL OF MEDICINAL CHEMISTRY
- Silencing of microRNA families by seed-targeting tiny LNAs
- (2011) Susanna Obad et al. NATURE GENETICS
- Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes
- (2011) Erich Koller et al. NUCLEIC ACIDS RESEARCH
- RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
- (2010) C. Frank Bennett et al. Annual Review of Pharmacology and Toxicology
- Allele-Selective Inhibition of MutantHuntingtinExpression with Antisense Oligonucleotides Targeting the Expanded CAG Repeat
- (2010) Keith T. Gagnon et al. BIOCHEMISTRY
- Structural basis for 5′-nucleotide base-specific recognition of guide RNA by human AGO2
- (2010) Filipp Frank et al. NATURE
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
- (2010) Mark E. Davis et al. NATURE
- Aptamers as therapeutics
- (2010) Anthony D. Keefe et al. NATURE REVIEWS DRUG DISCOVERY
- Modulation of thermal stability can enhance the potency of siRNA
- (2010) H. Addepalli et al. NUCLEIC ACIDS RESEARCH
- Synergistic effects between analogs of DNA and RNA improve the potency of siRNA-mediated gene silencing
- (2010) Glen F. Deleavey et al. NUCLEIC ACIDS RESEARCH
- Short locked nucleic acid antisense oligonucleotides potently reduce apolipoprotein B mRNA and serum cholesterol in mice and non-human primates
- (2010) Ellen Marie Straarup et al. NUCLEIC ACIDS RESEARCH
- A Direct Comparison of Anti-microRNA Oligonucleotide Potency
- (2010) Kim A. Lennox et al. PHARMACEUTICAL RESEARCH
- A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus
- (2010) J. DeVincenzo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Quantitative evaluation of siRNA delivery in vivo
- (2010) Y. Pei et al. RNA
- Antisense Drug Technology: Principles, Strategies, and Applications. Edited by Stanley T. Crooke.
- (2009) Kees Fluiter ChemMedChem
- G3139, an Anti-Bcl-2 Antisense Oligomer That Binds Heparin-Binding Growth Factors and Collagen I, Alters In vitro Endothelial Cell Growth and Tubular Morphogenesis
- (2009) C.A. Stein et al. CLINICAL CANCER RESEARCH
- 2′F-Arabinonucleic acids (2′F-ANA) — History, properties, and new frontiers
- (2008) Jonathan K Watts et al. CANADIAN JOURNAL OF CHEMISTRY
- Chemically modified siRNA: tools and applications
- (2008) J WATTS et al. DRUG DISCOVERY TODAY
- Short Antisense Oligonucleotides with Novel 2′−4′ Conformationaly Restricted Nucleoside Analogues Show Improved Potency without Increased Toxicity in Animals
- (2008) Punit P. Seth et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antisense transcripts are targets for activating small RNAs
- (2008) Jacob C Schwartz et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More